Results for tag: "Porokeratosis Drug"

Porokeratosis is a rare skin disorder characterized by the presence of raised, scaly patches on the skin. It is typically treated with topical medications, such as corticosteroids, retinoids, and calcineurin inhibitors. In more severe cases, systemic medications, such as methotrexate, may be prescribed. The Porokeratosis Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat a variety of skin conditions. These drugs are typically prescribed by dermatologists and are available in both prescription and over-the-counter forms. The Porokeratosis Drug market is highly competitive, with a number of companies offering products for the treatment of this condition. Some of the major players in this market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Johnson & Johnson. Other companies, such as Galderma, Mylan, and Sun Pharmaceuticals, also offer products for the treatment of Porokeratosis. Show Less Read more